190 related articles for article (PubMed ID: 25288494)
1. Structure-activity relationships of the thujaplicins for inhibition of human tyrosinase.
Yoshimori A; Oyama T; Takahashi S; Abe H; Kamiya T; Abe T; Tanuma S
Bioorg Med Chem; 2014 Nov; 22(21):6193-200. PubMed ID: 25288494
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the hot spot amino acid residues of mushroom tyrosinase for the bindings of thujaplicins.
Takahashi S; Kamiya T; Saeki K; Nezu T; Takeuchi S; Takasawa R; Sunaga S; Yoshimori A; Ebizuka S; Abe T; Tanuma S
Bioorg Med Chem; 2010 Nov; 18(22):8112-8. PubMed ID: 20947360
[TBL] [Abstract][Full Text] [Related]
3. Serendipitous discovery of short peptides from natural products as tyrosinase inhibitors.
Hsiao NW; Tseng TS; Lee YC; Chen WC; Lin HH; Chen YR; Wang YT; Hsu HJ; Tsai KC
J Chem Inf Model; 2014 Nov; 54(11):3099-111. PubMed ID: 25317506
[TBL] [Abstract][Full Text] [Related]
4. Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.
Ashraf Z; Rafiq M; Nadeem H; Hassan M; Afzal S; Waseem M; Afzal K; Latip J
PLoS One; 2017; 12(5):e0178069. PubMed ID: 28542395
[TBL] [Abstract][Full Text] [Related]
5. Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking.
Tan X; Song YH; Park C; Lee KW; Kim JY; Kim DW; Kim KD; Lee KW; Curtis-Long MJ; Park KH
Bioorg Med Chem; 2016 Jan; 24(2):153-9. PubMed ID: 26706112
[TBL] [Abstract][Full Text] [Related]
6. Modeling the met form of human tyrosinase: a refined and hydrated pocket for antagonist design.
Favre E; Daina A; Carrupt PA; Nurisso A
Chem Biol Drug Des; 2014 Aug; 84(2):206-15. PubMed ID: 24612747
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase.
Ashraf Z; Rafiq M; Seo SY; Kwon KS; Babar MM; Zaidi NU
Eur J Med Chem; 2015 Jun; 98():203-11. PubMed ID: 26025140
[TBL] [Abstract][Full Text] [Related]
8. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase-Targeting Gallacetophenone Inhibits Melanogenesis in Melanocytes and Human Skin-Equivalents.
Lee JY; Lee J; Min D; Kim J; Kim HJ; No KT
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365630
[TBL] [Abstract][Full Text] [Related]
10. Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors.
Radhakrishnan S; Shimmon R; Conn C; Baker A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4085-91. PubMed ID: 26318997
[TBL] [Abstract][Full Text] [Related]
11. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of hinokitiol on tyrosinase activity and melanin biosynthesis and its antimicrobial activities.
Zhu YJ; Qiu L; Zhou JJ; Guo HY; Hu YH; Li ZC; Wang Q; Chen QX; Liu B
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):798-803. PubMed ID: 20578978
[TBL] [Abstract][Full Text] [Related]
13. Reversible and competitive inhibitory kinetics of amoxicillin on mushroom tyrosinase.
Chen XX; Zhang J; Chai WM; Feng HL; Xiang ZH; Shen DY; Chen QX
Int J Biol Macromol; 2013 Nov; 62():726-33. PubMed ID: 24099941
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene(thio) barbiturates as novel tyrosinase inhibitors.
Chen Z; Cai D; Mou D; Yan Q; Sun Y; Pan W; Wan Y; Song H; Yi W
Bioorg Med Chem; 2014 Jul; 22(13):3279-84. PubMed ID: 24857777
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
Oyama T; Takahashi S; Yoshimori A; Yamamoto T; Sato A; Kamiya T; Abe H; Abe T; Tanuma SI
Bioorg Med Chem; 2016 Sep; 24(18):4509-4515. PubMed ID: 27507110
[TBL] [Abstract][Full Text] [Related]
16. Structural insight into the active site of mushroom tyrosinase using phenylbenzoic acid derivatives.
Oyama T; Yoshimori A; Takahashi S; Yamamoto T; Sato A; Kamiya T; Abe H; Abe T; Tanuma SI
Bioorg Med Chem Lett; 2017 Jul; 27(13):2868-2872. PubMed ID: 28495084
[TBL] [Abstract][Full Text] [Related]
17. Identification of Tyrosinase Inhibitors and Their Structure-Activity Relationships via Evolutionary Chemical Binding Similarity and Structure-Based Methods.
Durai P; Ko YJ; Kim JC; Pan CH; Park K
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499015
[TBL] [Abstract][Full Text] [Related]
18. The antibrowning agent sulfite inactivates Agaricus bisporus tyrosinase through covalent modification of the copper-B site.
Kuijpers TF; Gruppen H; Sforza S; van Berkel WJ; Vincken JP
FEBS J; 2013 Dec; 280(23):6184-95. PubMed ID: 24112416
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.
Tang J; Liu J; Wu F
Bioorg Chem; 2016 Dec; 69():29-36. PubMed ID: 27669118
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
